200 related articles for article (PubMed ID: 3698035)
21. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
[TBL] [Abstract][Full Text] [Related]
22. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
23. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
24. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
Wang H; Presland RB; Piepkorn M
Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma.
Isobe H; Sridhar KS; Doria R; Cohen F; Raub WA; Saldana M; Krishan A
Cytometry; 1995 Jan; 19(1):86-91. PubMed ID: 7705189
[TBL] [Abstract][Full Text] [Related]
26. [Expression of galanin in melanocytic tumors].
Gilaberte Y; Vera J; Coscojuela C; Roca MJ; Parrado C; González S
Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
[TBL] [Abstract][Full Text] [Related]
27. Malignant melanoma in children and congenital melanocytic nevi: DNA content and cell cycle analysis by flow cytometry.
Alvarez-Mendoza A; Reyes-Esparza J; Ruiz-Maldonado R; Lopez-Corella E; Juarez-Herrera NC
Pediatr Dev Pathol; 2001; 4(1):73-81. PubMed ID: 11200494
[TBL] [Abstract][Full Text] [Related]
28. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
[TBL] [Abstract][Full Text] [Related]
29. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
Indsto JO; Cachia AR; Kefford RF; Mann GJ
Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
[TBL] [Abstract][Full Text] [Related]
30. Congenital melanocytic nevi and DNA content. An analysis by flow and image cytometry.
Barnhill RL; Aguiar M; Cohen C; Kang S; Kennedy J; Schmidt B; Sober AJ; Solomon AR
Cancer; 1994 Dec; 74(11):2935-43. PubMed ID: 7954257
[TBL] [Abstract][Full Text] [Related]
31. [Characteristics of the DNA content in the cells of human pigmented nevi and of beginning and developed malignant melanomas of the skin].
Naleskina LA; Avtandilov GG
Tsitol Genet; 1987; 21(6):446-9. PubMed ID: 3445364
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
34. Improved detection of aneuploidy in malignant melanoma using multiparameter flow cytometry for S100 protein and DNA content.
Kamino H; Ratech H
J Invest Dermatol; 1989 Sep; 93(3):392-6. PubMed ID: 2768839
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic and predictive validity of DNA image cytometry in soft tissue tumors].
Bollmann R; Steinau HU; Bosse A
Verh Dtsch Ges Pathol; 1998; 82():351-7. PubMed ID: 10095459
[TBL] [Abstract][Full Text] [Related]
36. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
38. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
Kheir SM; Bines SD; Vonroenn JH; Soong SJ; Urist MM; Coon JS
Ann Surg; 1988 Apr; 207(4):455-61. PubMed ID: 3355269
[TBL] [Abstract][Full Text] [Related]
40. Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis.
Kamino H; Kiryu H; Ratech H
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1032-8. PubMed ID: 2370327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
